Author(s):
Dhanavath Mamata, Srinu Naik Sapavatu
Email(s):
mamatadhanavath@gmail.com
DOI:
10.52711/2231-5675.2022.00019
Address:
Dhanavath Mamata1*, Srinu Naik Sapavatu2
1Department of Pharmacy, University College of Technology, Osmania University, Hyderabad, Telangana, India, 500007.
2Department of Chemical Engineering, University College of Technology, Osmania University, Hyderabad, Telangana, India, 500007.
*Corresponding Author
Published In:
Volume - 12,
Issue - 2,
Year - 2022
ABSTRACT:
New RP-HPLC method have been developed for simultaneous analysis of lamivudine and dolutegravir in pharmaceutical dosage forms and applied to stability studies of drugs. The title analytes were eluted rapidly with phosphate buffer (pH 5.0) and acetonitrile (60:40 v/v) on Std discovery C18 (150 x 4.6 mm, 5 µ) column. The detection was carried out using PDA detector at 260 nm. The solutions were chromatographed at a constant flow rate of 1 mL/min. Lamivudine and Dolutegravir were eluted at 2.37 min and 2.97 min respectively with good resolution. Method was validated as ICH guidelines. The linearity range of lamivudine and dolutegravir were found to be of 18.75 - 112.5 µg/mL and 3.125 - 18.75 µg/mL, respectively. The % RSD values (< 2) in precision studies indicates the reproducibility of method. The percentage recoveries were 100.17 % and 100.36 % respectively for lamivudine and dolutegravir, found to be within the limits. The proposed validated method was fruitfully applied for assay of formulation and stability studies of drugs under various stress conditions.
Cite this article:
Dhanavath Mamata, Srinu Naik Sapavatu. RP-HPLC method for swift analysis of Lamivudine and Dolutegravir in formulation, stability studies. Asian Journal of Pharmaceutical Analysis. 2022; 12(2):105-0. doi: 10.52711/2231-5675.2022.00019
Cite(Electronic):
Dhanavath Mamata, Srinu Naik Sapavatu. RP-HPLC method for swift analysis of Lamivudine and Dolutegravir in formulation, stability studies. Asian Journal of Pharmaceutical Analysis. 2022; 12(2):105-0. doi: 10.52711/2231-5675.2022.00019 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2022-12-2-7
REFERENCES:
1. Ribera E. Podzamczer D. Mechanisms of action, pharmacology and interactions of dolutegravir. Enfermedades infeccios as Microbiología Clínica. 2015; 33(1): 2–8. https://doi.org/10.1016/s0213-005x(15)30002-1
2. Swathi N. Durai AKT. Sunitha G. Asra J. Pani Kumar DA. Spectrophotometric quantification of dolutegravir based on redox reaction with Fe3+/1,10-phenanthroline. Future Journal of Pharmaceutical Sciences. 2020; 6:107. https://doi.org/10.1186/s43094-020-00121-2
3. Balasaheb BG. Balasaheb AK. Subhash TR. Jijabapu K. Sudhakar PS. Development and validation of UV spectrophotometric method for estimation of dolutegravir sodium in tablet dosage form. Malaysian Journal of Analytical Chemistry. 2015; 19:1156–1163.
4. Madu KC. Ukoha PO. Attama AA. Spectrophotometric determination of lamivudine using chloranilic acid and 2,3-dichloro-5,6-dicyano-1,4- benzoquinone (DDQ). American Journal of Analytical Chemistry. 2011; 2(7): 849–856. http://dx.doi.org/10.4236/ajac.2011.27097
5. Deepali G. Elvis M. UV Spectrophotometric method for assay of the anti-retroviral agent lamivudine in active pharmaceutical ingredient and in its tablet formulation. Journal of Young Pharmacists. 2010; 2(4): 417–419.
6. Gurrala S. Anumolu PD. Subrahmanyam CVS. Mounika G. Priyanka B. Stability indicating liquid chromatographic assessment of dolutegravir by AQbD approach – central composite design. Indian Drugs. 2017; 54(10): 44-51.
7. Bhavar GB. Pekamwar SS. Aher KB. Thorat RS. Chaudhari SR. High performance liquid chromatographic and high-performance thin-layer chromatographic method for the quantitative estimation of dolutegravir sodium in bulk drug and pharmaceutical dosage form. Sci Pharmtech. 2016; 84: 305–320. https://doi.org/10.3797/scipharm.1507-09
8. Vikram SA. Nath LK. Pani NR. Development and validation of analytical method for estimation of lamivudine in rabbit plasma. Journal of Pharmaceutical Analysis. 2011; 1(4): 251–257. https://doi.org/10.1016/j.jpha.2011.08.001
9. Ramreddy G. Sowjanya G. An effective stability indicating RP-HPLC method for simultaneous estimation of dolutegravir and lamivudine in bulk and their tablet dosage form. Future Journal of Pharmaceutical Sciences. 2020; 6: 9. https://doi.org/10.1186/s43094-020-00026-0
10. Noorbasha K. Nurbhasha S. A new validated stability-indicating RP-HPLC method for simultaneous quantification of dolutegravir and lamivudine in bulk and pharmaceutical dosage form. Future Journal of Pharmaceutical Sciences. 2020; 6: 39. https://doi.org/10.1186/s43094-020-00060-y
11. Sapna MR. Paresh UP. Development and validation of RP – HPLC method for estimation of lamivudine and dolutegravir sodium in synthetic mixture. Research Journal of Pharmacy and Technology. 2020; 13(6): 2864-2868. https://doi.org/10.5958/0974-360X.2020.00510.7
12. Prasada RP. RP-HPLC method development and validation for the simultaneous estimation of dolutegravir and lamivudine in drug product. European Journal of Biomedical & Pharmaceutical Sciences. 2018; 5(7): 538-543.
13. Devanna N. Benzil Dudekula. Ramachandraiah C. Development and validation for the simultaneous estimation of dolutegravir and lamivudine in drug product by RP-HPLC. International journal of Research in Pharmaceutical and Nano Sciences. 2017; 6(4): 173 - 180.
14. Mallikarjuna RN. Gowri SD. Development and validation of stability-indicating HPLC method for simultaneous determination of lamivudine, tenofovir and dolutegravir in bulk and their tablet dosage form. Future Journal of Pharmaceutical Sciences. 2015; 1(2): 73-77. https://doi.org/10.1016/j.fjps.2015.11.002
15. Mastanamma SK. Asha Jyothi J. Saidulu P. Varalakshmi M. Development and validation of RP-HPLC method for the simultaneous estimation of lamivudine, tenofovir alafenamide and dolutegravir bulk and their combined dosage form. Pharmaceutical Methods. 2018; 9(2): 49-55.
16. Cozzi V. Charbe N. Baldelli S. Castoldi S. Atzori C. Cattaneo D. Clementi E. Development and validation of a chromatographic ultraviolet method for the simultaneous quantification of dolutegravir and rilpivirine in human plasma. Therapeutic Drug Monitoring. 2016; 38 (3): 407–413. https://doi.org/10.1097/ftd.0000000000000290
17. Khaleel N. SK AR. A validated stability indicating RP-HPLC method for simultaneous determination of abacavir, lamivudine and dolutegravir in bulk and pharmaceutical dosage form. World Journal of Pharmaceutical Research. 2015; 4(7):1453–1476.
18. Sufiyan ARA. Lalit P. Mohammed RMU. Mohammad I. Rashid A. Analytical method development and validation for the simultaneous estimation of abacavir and lamivudine by reversed-phase high-performance liquid chromatography in bulk and tablet dosage forms. Pharmacognosy Research. 2018; 10(1): 92-97. https://doi.org/10.4103/pr.pr_96_17
19. Krishnamoorthy G. Gayathri N. Gnanaraja M. Senthamarai R. Assay of lamivudine in pharmaceutical preparations by spectrophotometric method. Asian Journal of Pharmaceutical Analysis. 2012; 2(3): 77-78.
20. Thenmozhi A. Sridharan D. Veeramani S. Palanivelu M. An RP-HPLC method for the estimation of dexibuprofen in pharmaceutical tablet dosage form. Asian Journal of Pharmaceutical Analysis. 2011; 1(4): 98-99.
21. Ahsanul MH. Mohammad S. Parvin MN, Ashraful Islam SM. Validated RP-HPLC method for estimation of ranitidine hydrochloride, domperidone and naproxen in solid dosage form. Asian Journal of Pharmaceutical Analysis. 2011; 1(3): 59-63.
22. Sharmin RC. Mahfuza M. Mahbubul HS. Development and validation of a simple RP-HPLC method for determination of caffeine in pharmaceutical dosage forms. Asian Journal of Pharmaceutical Analysis. 2012; 2(1): 01-04.
23. Janaki PP. Appala RN. Parvathalu G. The estimation of sapropterin dihydrochloride in tablet dosage form by RP-HPLC. Asian Journal of Pharmaceutical Analysis. 2012; 2(4): 110-113.
24. Revathi R. Venkata NSP. Koteswara RM. Ethiraj T. Rajarajan S. Development and validation of RP-HPLC method for content analysis of didanosine in dosage form. Asian Journal of Pharmaceutical Analysis. 2012; 2(4): 118-121.
25. Renu S. Badri PN. Mahendra KN. Joytosh B. Development and validation of simultaneous estimation method for amoxycillin trihydrate and tinidazole in tablet dosage form by RP-HPLC. Asian Journal of Pharmaceutical Analysis. 2013; 3(2): 66-71.
26. Thangabalan B. Salomi M. Sunitha N, Manohar BS. Development of validated RP-HPLC method for the estimation of Itraconazole in pure and pharmaceutical dosage form. Asian journal of Pharmaceutical Analysis. 2013; 3(4): 119-123.
27. Niraj V. Sangita P. Development and validation of RP-HPLC method for simultaneous estimation of nebivolol and indapamide in pharmaceutical dosage form. Asian Journal of Pharmaceutical Analysis. 2014; 4(3): 98-102.
28. Kumaraswamy G. Zeeshan HMA. Suthakaran R. Development and validation of RP-HPLC for simultaneous estimation of cefpodoxime proxetil and dicloxacillin sodium tablets. Asian Journal of Pharmaceutical Analysis. 2014; 4(4): 151-155.
29. Vijaya SK. Anusha M. Ravinder RS. A Rapid RP-HPLC Method development and validation for the analysis of linagliptin bulk and pharmaceutical dosage form. Asian Journal of Pharmaceutical Analysis. 2015; 5(1): 16-20.
30. Jayshree P. Sandeep S. Santosh C. Sanjay K. Development and validation of RP-HPLC method for simultaneous estimation of metformin HCl and gliclazide. Asian Journal of Pharmaceutical Analysis. 2016; 6(3): 151-154.
31. ICH Q2 (R1) International Conference on Harmonization, Harmonized Tripartite Guideline. Validation of analytical procedures: Text and Methodology, IFPMA, 2005. Geneva.
32. ICH Q1A (R2) International Conference on Harmonization, Harmonized Tripartite Guideline. Stability testing of new drug substances and products, IFPMA, 2003. Geneva.